Efficacy of mizoribine pulse therapy in patients with rheumatoid arthritis who show a reduced or insufficient response to infliximab

The efficacy of infliximab, a chimeric antibody against tumor necrosis factor-α used to treat patients with rheumatoid arthritis (RA), tends to decrease as patients develop human antichimeric antibody against infliximab (HACA). The clinical study reported here was designed to evaluate the efficacy o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Horikoshi, Masanobu, Ito, Satoshi, Ishikawa, Mizue, Umeda, Naoto, Kondo, Yuya, Tsuboi, Hiroto, Hayashi, Taichi, Goto, Daisuke, Matsumoto, Isao, Sumida, Takayuki
Format: Artigo
Idioma:Inglês
Publicat: Springer Japan 2009
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2689357/
https://ncbi.nlm.nih.gov/pubmed/19326186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10165-009-0162-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars